Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study
International Journal of STD & AIDS · 2023
DOI: 10.1177/09564624231152776 ↗Kurz gefasst
Qualitative Studie in der Zeitschrift International Journal of STD & AIDS, 2023. Verfasst von Sonia Haribhai und 8 weiteren Autor:innen. Beteiligte Einrichtung: Desmond Tutu Health Foundation/International AIDS Vaccine Initiative Fellowship, Desmond Tutu Health Foundation, Cape Town, South Africa. Hauptthemen laut MEDLINE: Pre-Exposure Prophylaxis, HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: NICHD NIH HHS, FIC NIH HHS, NIMH NIH HHS.
Abstract (Originalsprache)
Background
In South Africa, at least 7.5 million people (age ≥15 years) are living with Human Immunodeficiency Virus (HIV). In 2020, 220,000 new infections occurred, approximately one-third of which were among cisgender adolescent girls and women (age ≥15 years). The perspectives of pregnant adolescent girls and young women (AGYW) as key, targeted end-users of pre-exposure prophylaxis (PrEP) in this setting are not well known.
Methods
We purposively recruited participants enrolled in an ongoing cohort study at an urban antenatal clinic in Cape Town, South Africa for in-depth interviews between July–September 2020. We restricted our analysis to pregnant AGYW (age: 16–25 years) who initiated daily oral PrEP (Tenofovir/Emtricitabine) antenatally and self-reported either high PrEP persistence (≥25 days in the past 30 days and no missed PrEP collection), or low PrEP persistence and/or discontinuation (missing >5 days in the last 30 days or missed PrEP collection). The findings were organized thematically, per the adapted Health Behavior Model (2000), using Nvivo -v.1.5.
Results
We interviewed 18 AGYW (mean age = 22 years), at a mean of 14 weeks postpartum. Higher self-esteem and high-quality study provider-client relationships, including empathic psychosocial support, facilitated PrEP continuation. Reported barriers included unstable social structure characteristics (i.e., financial hardship) and individual factors (i.e., unintended pregnancy, parental rejection, and inadequate peer- and [non-cohabiting] partner support). Participants self-perceived a need for PrEP, feeling susceptible to non-consensual, forced sex, or considering partners’ (presumed) sexual risk-taking. Limited community awareness regarding PrEP availability and/or perceived complexity in navigating health system access to PrEP, impede continuation.
Conclusions
PrEP-focused healthcare access pathways for pregnant and postpartum AGYW need to be simplified. Further research is needed on health system determinants (i.e., structural barriers, provider-client interactions, and related outcomes) of oral PrEP utilization. In 2022, South Africa announced regulatory approval of long-acting PrEP options (i.e., the dapivirine ring for non-pregnant women and injectable cabotegravir, respectively); these may mitigate implementation barriers reported in this study. However, the safety and efficacy of long-acting PrEP (e.g., injectables, implants) among pregnant or breastfeeding women, specifically, remains to be confirmed in this setting.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Desmond Tutu Health Foundation/International AIDS Vaccine Initiative Fellowship, Desmond Tutu Health Foundation, Cape Town, South Africa.
- Department of Epidemiology, Fielding School of Public Health, University of California Los Angeles, Los Angeles, CA, USA.
- Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
- The Desmond Tutu HIV Centre, University of Cape Town, Cape Town, South Africa.
- Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA.
ORCID-Profile: Sonia Haribhai, Dvora Leah Joseph Davey
Förderung
- NICHD NIH HHS
- FIC NIH HHS
- NIMH NIH HHS
- Fogarty International Center
- National Institute of Mental Health
Zitieren
APA
Haribhai, S., Khadka, N., Mvududu, R., Mashele, N., Bekker, L. G., Gorbach, P., Coates, T. J., Myer, L., & Joseph Davey, D. L. (2023). Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study. International Journal of STD & AIDS. https://doi.org/10.1177/09564624231152776
Vancouver
Haribhai S, Khadka N, Mvududu R, Mashele N, Bekker LG, Gorbach P, et al. Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study. International Journal of STD & AIDS. 2023. doi:10.1177/09564624231152776
BibTeX
@article{Haribhai2023,
author = {Haribhai, Sonia and Khadka, Nehaa and Mvududu, Rufaro and Mashele, Nyiko and Bekker, Linda-Gail and Gorbach, Pamina and Coates, Thomas J and Myer, Landon and Joseph Davey, Dvora Leah},
title = {Psychosocial determinants of pre-exposure prophylaxis use among pregnant adolescent girls and young women in Cape Town, South Africa: A qualitative study},
journal = {International Journal of STD & AIDS},
year = {2023},
doi = {10.1177/09564624231152776}
}
EUVIMED